Source |
Alliance of Genome Resources |
Category | ID | Classification term | Gene | Evidence | Inferred from | Organism | Reference |
---|---|---|---|---|---|---|---|
Molecular Function | GO:0030234 | enzyme regulator activity | APOC3 | IDA | Human | PMID:11060345 | |
Molecular Function | GO:0070653 | high-density lipoprotein particle receptor binding | APOC3 | IPI | UniProtKB:Q61009 | Human | PMID:9254056 |
Molecular Function | GO:0055102 | lipase inhibitor activity | APOC3 | IDA | Human | PMID:15576844 | |
Molecular Function | GO:0055102 | lipase inhibitor activity | APOC3 | IDA | Human | PMID:182536 | |
Molecular Function | GO:0055102 | lipase inhibitor activity | APOC3 | IDA | Human | PMID:18635818 | |
Molecular Function | GO:0055102 | lipase inhibitor activity | APOC3 | IDA | Human | PMID:3973011 | |
Molecular Function | GO:0005543 | phospholipid binding | APOC3 | IDA | Human | PMID:11060345 | |
Molecular Function | GO:0005543 | phospholipid binding | APOC3 | IDA | Human | PMID:4066713 | |
Molecular Function | GO:0005515 | protein binding | APOC3 | IPI | UniProtKB:Q5JX71 | Human | PMID:32296183 |
Molecular Function | GO:0005515 | protein binding | APOC3 | IPI | UniProtKB:Q8TED1 | Human | PMID:32296183 |
Molecular Function | GO:0005515 | protein binding | APOC3 | IPI | UniProtKB:Q9Y282 | Human | PMID:32296183 |
Cellular Component | GO:0042627 | chylomicron | APOC3 | IDA | Human | PMID:8245722 | |
Cellular Component | GO:0062023 | collagen-containing extracellular matrix | APOC3 | HDA | Human | PMID:27068509 | |
Cellular Component | GO:0062023 | collagen-containing extracellular matrix | APOC3 | HDA | Human | PMID:27559042 | |
Cellular Component | GO:0070062 | extracellular exosome | APOC3 | HDA | Human | PMID:23533145 | |
Cellular Component | GO:0005615 | extracellular space | APOC3 | IDA | Human | PMID:11060345 | |
Cellular Component | GO:0005615 | extracellular space | Apoc3 | IDA | Rat | PMID:21183731|RGD:7207206 | |
Cellular Component | GO:0005615 | extracellular space | Apoc3 | IDA | Rat | PMID:6419747|RGD:1599195 | |
Cellular Component | GO:0034363 | intermediate-density lipoprotein particle | APOC3 | IDA | Human | PMID:17336988 | |
Cellular Component | GO:0034366 | spherical high-density lipoprotein particle | APOC3 | IDA | Human | PMID:17438339 | |
Cellular Component | GO:0034361 | very-low-density lipoprotein particle | APOC3 | IDA | Human | PMID:16935699 | |
Cellular Component | GO:0034361 | very-low-density lipoprotein particle | APOC3 | IDA | Human | PMID:17154273 | |
Cellular Component | GO:0034361 | very-low-density lipoprotein particle | APOC3 | IDA | Human | PMID:3973011 | |
Biological Process | GO:0071333 | cellular response to glucose stimulus | Apoc3 | IDA | Rat | PMID:21183731|RGD:7207206 | |
Biological Process | GO:0033344 | cholesterol efflux | APOC3 | IDA | Human | PMID:11162594 | |
Biological Process | GO:0033344 | cholesterol efflux | APOC3 | IDA | Human | PMID:16443932 | |
Biological Process | GO:0042632 | cholesterol homeostasis | APOC3 | IMP | Human | PMID:18767813 | |
Biological Process | GO:0008203 | cholesterol metabolic process | Apoc3 | IMP | MGI:MGI:1857128 | Mouse | PMID:8089130 |
Biological Process | GO:0008203 | cholesterol metabolic process | Apoc3 | IMP | MGI:MGI:1857128 | Mouse | PMID:11590213 |
Biological Process | GO:0008203 | cholesterol metabolic process | Apoc3 | IMP | MGI:MGI:3758464 | Mouse | PMID:8864964 |
Biological Process | GO:0034382 | chylomicron remnant clearance | APOC3 | IDA | Human | PMID:4020294 | |
Biological Process | GO:0007186 | G protein-coupled receptor signaling pathway | APOC3 | IDA | Human | PMID:16443932 | |
Biological Process | GO:0034375 | high-density lipoprotein particle remodeling | APOC3 | IMP | Human | PMID:17438339 | |
Biological Process | GO:0006954 | inflammatory response | Apoc3 | IEP | Rat | PMID:8491512|RGD:1599189 | |
Biological Process | GO:0042953 | lipoprotein transport | Apoc3 | IDA | Rat | PMID:4020294|RGD:1599181 | |
Biological Process | GO:0060621 | negative regulation of cholesterol import | APOC3 | IMP | Human | PMID:15778093 | |
Biological Process | GO:0045717 | negative regulation of fatty acid biosynthetic process | APOC3 | IDA | Human | PMID:11060345 | |
Biological Process | GO:0045717 | negative regulation of fatty acid biosynthetic process | APOC3 | IDA | Human | PMID:18635818 | |
Biological Process | GO:0010987 | negative regulation of high-density lipoprotein particle clearance | APOC3 | IMP | Human | PMID:15778093 | |
Biological Process | GO:0050995 | negative regulation of lipid catabolic process | APOC3 | IDA | Human | PMID:15576844 | |
Biological Process | GO:0045833 | negative regulation of lipid metabolic process | APOC3 | IDA | Human | PMID:182536 | |
Biological Process | GO:0051005 | negative regulation of lipoprotein lipase activity | APOC3 | IDA | Human | PMID:11060345 | |
Biological Process | GO:0051005 | negative regulation of lipoprotein lipase activity | APOC3 | IDA | Human | PMID:18635818 | |
Biological Process | GO:0051005 | negative regulation of lipoprotein lipase activity | APOC3 | IDA | Human | PMID:3973011 | |
Biological Process | GO:0010989 | negative regulation of low-density lipoprotein particle clearance | APOC3 | IMP | Human | PMID:15778093 | |
Biological Process | GO:0090324 | negative regulation of oxidative phosphorylation | Apoc3 | IDA | Rat | PMID:11177239|RGD:1599177 | |
Biological Process | GO:0048261 | negative regulation of receptor-mediated endocytosis | APOC3 | IDA | Human | PMID:1917954 | |
Biological Process | GO:0010897 | negative regulation of triglyceride catabolic process | APOC3 | IDA | Human | PMID:18635818 | |
Biological Process | GO:0010897 | negative regulation of triglyceride catabolic process | APOC3 | IDA | Human | PMID:3973011 | |
Biological Process | GO:0010916 | negative regulation of very-low-density lipoprotein particle clearance | APOC3 | IDA | Human | PMID:1917954 | |
Biological Process | GO:0010903 | negative regulation of very-low-density lipoprotein particle remodeling | APOC3 | IDA | Human | PMID:3973011 | |
Biological Process | GO:0033700 | phospholipid efflux | APOC3 | IDA | Human | PMID:11162594 | |
Biological Process | GO:0010867 | positive regulation of triglyceride biosynthetic process | Apoc3 | IMP | Rat | PMID:23542898|RGD:10054091 | |
Biological Process | GO:0032489 | regulation of Cdc42 protein signal transduction | APOC3 | IDA | Human | PMID:16443932 | |
Biological Process | GO:0070542 | response to fatty acid | Apoc3 | IEP | Rat | PMID:20938723|RGD:10054090 | |
Biological Process | GO:0007584 | response to nutrient | Apoc3 | IEP | Rat | PMID:7811230|RGD:1599187 | |
Biological Process | GO:0043434 | response to peptide hormone | Apoc3 | IDA | Rat | PMID:8429259|RGD:1599190 | |
Biological Process | GO:0034014 | response to triglyceride | Apoc3 | IEP | Rat | PMID:6698975|RGD:10054046 | |
Biological Process | GO:0033189 | response to vitamin A | Apoc3 | IEP | Rat | PMID:7811230|RGD:1599187 | |
Biological Process | GO:0009410 | response to xenobiotic stimulus | Apoc3 | IEP | Rat | PMID:10386582|RGD:10054089 | |
Biological Process | GO:0009410 | response to xenobiotic stimulus | Apoc3 | IEP | Rat | PMID:9888873|RGD:1599178 | |
Biological Process | GO:0019433 | triglyceride catabolic process | APOC3 | IDA | Human | PMID:11060345 | |
Biological Process | GO:0019433 | triglyceride catabolic process | Apoc3 | IMP | MGI:MGI:1857128 | Mouse | PMID:11590213 |
Biological Process | GO:0070328 | triglyceride homeostasis | APOC3 | IMP | Human | PMID:18767813 | |
Biological Process | GO:0006641 | triglyceride metabolic process | APOC3 | IMP | Human | PMID:17142127 | |
Biological Process | GO:0006641 | triglyceride metabolic process | Apoc3 | IMP | MGI:MGI:1857128 | Mouse | PMID:8089130 |
Biological Process | GO:0006641 | triglyceride metabolic process | Apoc3 | IMP | MGI:MGI:1857128 | Mouse | PMID:11590213 |
Biological Process | GO:0006642 | triglyceride mobilization | Apoc3 | IMP | MGI:MGI:3758464 | Mouse | PMID:8864964 |
Biological Process | GO:0006642 | triglyceride mobilization | Apoc3 | IMP | MGI:MGI:1857128 | Mouse | PMID:11551841 |
EXP Inferred from experiment |
IDA Inferred from direct assay |
IEP Inferred from expression pattern |
IGI Inferred from genetic interaction |
IMP Inferred from mutant phenotype |
IPI Inferred from physical interaction |
HTP Inferred from High Throughput Experiment |
HDA Inferred from High Throughput Direct Assay |
HMP Inferred from High Throughput Mutant Phenotype |
HGI Inferred from High Throughput Genetic Interaction |
HEP Inferred from High Throughput Expression Pattern |
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 12/10/2024 MGI 6.24 |
|
|